Literature DB >> 25654597

Response to burgess.

Douglas E Befroy1, Richard G Kibbey2, Rachel J Perry2, Kitt Falk Petersen3, Douglas L Rothman4, Gerald I Shulman5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25654597      PMCID： PMC4400583          DOI： 10.1038/nm.3790

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Some factors regulating the rate of gluconeogenesis in animal tissues.

Authors:  H A Krebs; E A Newsholme; R Speake; T Gascoyne; P Lund
Journal:  Adv Enzyme Regul       Date:  1964

2.  13C isotopomer model for estimation of anaplerotic substrate oxidation via acetyl-CoA.

Authors:  F M Jeffrey; C J Storey; A D Sherry; C R Malloy
Journal:  Am J Physiol       Date:  1996-10

3.  Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease.

Authors:  Nishanth E Sunny; Elizabeth J Parks; Jeffrey D Browning; Shawn C Burgess
Journal:  Cell Metab       Date:  2011-12-07       Impact factor: 27.287

4.  Limitations of detection of anaplerosis and pyruvate cycling from metabolism of [1-(13)C] acetate.

Authors:  Shawn C Burgess; Mathew E Merritt; John G Jones; Jeffrey D Browning; A Dean Sherry; Craig R Malloy
Journal:  Nat Med       Date:  2015-02       Impact factor: 53.440

5.  Triiodothyronine treatment increases substrate cycling between pyruvate carboxylase and malic enzyme in perfused rat liver.

Authors:  K F Petersen; J B Blair; G I Shulman
Journal:  Metabolism       Date:  1995-11       Impact factor: 8.694

6.  Role of pyruvate kinase in the regulation of gluconeogenesis from L-lactate.

Authors:  R Rognstad; J Katz
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

7.  13C NMR study of gluconeogenesis from labeled alanine in hepatocytes from euthyroid and hyperthyroid rats.

Authors:  S M Cohen; P Glynn; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C]propionate, phenylacetate, and acetaminophen.

Authors:  J G Jones; M A Solomon; A D Sherry; F M Jeffrey; C R Malloy
Journal:  Am J Physiol       Date:  1998-11

9.  Substrate cycling between pyruvate and oxaloacetate in awake normal and 3,3'-5-triiodo-L-thyronine-treated rats.

Authors:  K F Petersen; G W Cline; J B Blair; G I Shulman
Journal:  Am J Physiol       Date:  1994-08

10.  Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy.

Authors:  Douglas E Befroy; Rachel J Perry; Nimit Jain; Sylvie Dufour; Gary W Cline; Jeff K Trimmer; Julia Brosnan; Douglas L Rothman; Kitt Falk Petersen; Gerald I Shulman
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440
  10 in total
  4 in total

1.  Mass spectrometry-based microassay of (2)H and (13)C plasma glucose labeling to quantify liver metabolic fluxes in vivo.

Authors:  Clinton M Hasenour; Martha L Wall; D Emerson Ridley; Curtis C Hughey; Freyja D James; David H Wasserman; Jamey D Young
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-19       Impact factor: 4.310

2.  In Vivo Estimates of Liver Metabolic Flux Assessed by 13C-Propionate and 13C-Lactate Are Impacted by Tracer Recycling and Equilibrium Assumptions.

Authors:  Clinton M Hasenour; Mohsin Rahim; Jamey D Young
Journal:  Cell Rep       Date:  2020-08-04       Impact factor: 9.423

3.  Assessment of Hepatic Mitochondrial Oxidation and Pyruvate Cycling in NAFLD by (13)C Magnetic Resonance Spectroscopy.

Authors:  Kitt Falk Petersen; Douglas E Befroy; Sylvie Dufour; Douglas L Rothman; Gerald I Shulman
Journal:  Cell Metab       Date:  2016-07-12       Impact factor: 27.287

4.  Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA).

Authors:  Rachel J Perry; Liang Peng; Gary W Cline; Gina M Butrico; Yongliang Wang; Xian-Man Zhang; Douglas L Rothman; Kitt Falk Petersen; Gerald I Shulman
Journal:  Nat Commun       Date:  2017-10-06       Impact factor: 14.919
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.